Medigen Vaccine Biologics Corp. said Sunday it will soon apply to the Food and Drug Administration in Taiwan and other countries for new drug approval for its enterovirus 71 (EV71) vaccine, as it has successfully completed its Phase III clinical trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Formosa Smart Energy partners with Polish group on new energy projects
07/02/2025 03:16 PM - Business
Taipei Fubon Bank secures FSC approval to open branch in India
07/02/2025 03:05 PM - Politics
Senior KMT official detained in Pingtung recall forgery case
07/02/2025 02:01 PM - Business
Taiwan shares close up 0.11%
07/02/2025 01:54 PM - Business
Stock trading accounts hit new high despite U.S. tariff concerns
07/02/2025 12:47 PM